Pharma Capital
EPIC: CIR
Market: LSE
52-week High/Low: 114.00p / 78.45p
Sector: Pharma & Biotech
Market Cap: 297.36M
Phone: +44 (0)1865 405560
Address: The Magdalen Centre, Robert Robinson Avenue, Oxford Science Park OX4 4GA.
Website: www.circassia.co.uk

Circassia (CIR:LSE) is a speciality biopharmaceutical company focused on the development of novel immunotherapies. These are designed to treat a range of common allergies and autoimmune conditions by controlling patients’ inappropriate immune responses. Our most advanced product, Cat-SPIRE, has achieved highly impressive results in clinical studies, and is currently in the final phase of testing for cat allergy.

Circassia Pharmaceuticals

www.circassia.co.uk

Interactive graph

col 3
col 4
col 5
col 6

Circassia Pharmaceuticals Timeline

View All

Market Reports Including CIR

VIEW ALL

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.